USMJ and KALY To Present Meatless CBD Infused Burger Plan For WCVC Partnership Next Week Thursday June 27th
June 21 2019 - 11:17AM
InvestorsHub NewsWire
USMJ and KALY To Present Meatless
CBD Infused Burger Plan For WCVC Partnership Next Week Thursday
June 27th
Dallas, TX -- June 21, 2019 --
InvestorsHub NewsWire -- North American Cannabis Holdings, Inc.
(USOTC:
USMJ) (“USMJ”) and Kali-Extracts (aka Kali, Inc.)
(USOTC:
KALY) (“KALY”) today announced a presentation scheduled to be
released online next week on Thursday, June
27th, detailing
their partnership to introduce a meatless hamburger infused with
CBD. Plant based protein alternatives to meat are growing in
popularity with consumers. The recently Beyond Meat (NASDAQ:
BYND) partnership with Del Taco introducing meatless tacos has
brought a groundswell of attention to the plant based protein
sector. USMJ spun its cannabis themed restaurant off last
fall to capitalize and expand the initiative in a partnership
with West Coast Venture Group,
Corp. (WCVC) (“WCVC”)
the owner and operator of Illegal
Burger operating in cannabis friendly Colorado. USMJ CEO
Steven Rash currently serves as the CEO of the USMJ cannabis themed
restaurant spinoff Now, USMJ is partnering with KALY, the owner and
operator of a US Patented Cannabis Extraction product to introduce
a meatless CBD infused burger.
To learn more
visit www.USMJ.com
and www.GrowUSMJ.com.
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any
disease.
Steven
Rash
CEO
North American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350